Received Jul 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | 3334Y | — |
got a 3rd dose of Shingrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 63-year-old male patient who received Herpes zoster (Shingrix) (batch number 3334Y, expiry date 21-MAR-2027) for prophylaxis. Previously administered products included Shingrix (patient had the 1st dose of Shingrix in 20-JAN-2022) and Shingrix (2rd dose was received by patient in 21-MAR-2022). On 10-MAR-2025, the patient received the 3rd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: got a 3rd dose of Shingrix). The outcome of the extra dose administered was not applicable. Additional Information: GSK Receipt Date: 18-JUL-2025 On 18/Jul/2025, Nurse called to informed that a patient accidentally got a 3rd dose of Shingrix, which led to Extra dose administered. They have had 3 Shingrix injections total. Reporter informed that patient had the 1st dose of Shingrix in 20/Jan/2022,2nd dose in 21/Mar/2022, and the 3rd dose was received by patient in 10/Mar/2022. No further details were provided. The reporter was Consented to follow up.